Skip to main content

MCR

ETF
Financials
Asset Management

Performance overview

MCR Price
Price Chart

Forward-looking statistics

Beta
0.27
Risk
8.73%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.

Fund info

MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.

Investing methodUnknown
DiversifiedNo
Expense ratio—
Asset classUnknown

Top holdings

Other100.00%

Sector exposure

Other100.00%

Country exposure

Other100.00%

Company info

SectorFinancials
IndustryAsset Management
AUM$266.8M

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)$0.72
Dividend per share$0.54
Revenue per share$0.54
Avg trading volume (30 day)$359K
Avg trading volume (10 day)$459K
Put-call ratioN/A

Macro factor sensitivity

Growth-1.0
Credit+1.9
Liquidity+0.3
Inflation-1.5
Commodities-0.7
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

News

Exploring Analyst Estimates for Monarch Casino (MCRI) Q2 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Monarch Casino (MCRI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Zacks Investment Research (July 11, 2025)
Amcor Boosts PCR Capabilities With Latest Investment in Kentucky

AMCR boosts PCR packaging at its Kentucky site, giving brands more control over recycled content in their products.

Zacks Investment Research (July 7, 2025)
AMCR or AVY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Containers - Paper and Packaging sector might want to consider either Amcor (AMCR) or Avery Dennison (AVY). But which of these two stocks is more attractive to value investors?

Zacks Investment Research (July 2, 2025)
5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position EXEL, VRNA, ALKS, KNSA and IMCR well in this volatile sector.

Zacks Investment Research (July 2, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free